BWLCX | VIVIX | BWLCX / VIVIX | |
Total Expense Ratio | 1.94 | 0.04 | 4,850% |
Annual Report Gross Expense Ratio | 1.94 | 0.04 | 4,850% |
Fund Existence | 13 years | 27 years | - |
Gain YTD | 8.903 | 6.730 | 132% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 226M | 195B | 0% |
Annual Yield % from dividends | 0.00 | 2.19 | - |
Returns for 1 year | -3.93 | 9.75 | -40% |
Returns for 3 years | 6.46 | 34.32 | 19% |
Returns for 5 years | 15.42 | 74.87 | 21% |
Returns for 10 years | 6.70 | 116.26 | 6% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETHSX | 13.09 | 0.06 | +0.46% |
Eaton Vance Worldwide Health Sci A | |||
IACIX | 12.04 | 0.05 | +0.42% |
VY® American Century Sm-Mid Cp Val I | |||
TIBRX | 30.73 | 0.02 | +0.07% |
Thornburg Investment Income Builder R3 | |||
AIIEX | 23.93 | -0.08 | -0.33% |
Invesco EQV International Equity A | |||
JOMEX | 15.13 | -0.13 | -0.85% |
JOHCM Emerging Mkts Discovery Advisor |